Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Daily News

Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim

November 24, 2021

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

News Conference News

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

November 16, 2021

Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death

News Daily News

Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death

November 11, 2021

Case-Based Presentation 5: INOCA – How to Diagnose and Treat Coronary Microvascular Dysfunction (CMD)

Presentation TCT 2021

Case-Based Presentation 5: INOCA – How to Diagnose and Treat Coronary Microvascular Dysfunction (CMD)

Presenter: Colin Berry

November 06, 2021

How Do We Identify Patients With Microvascular Dysfunction and Define Their Risk (Pressure Wire, Angiography, MRI)?

Presentation TCT 2021

How Do We Identify Patients With Microvascular Dysfunction and Define Their Risk (Pressure Wire, Angiography, MRI)?

Presenter: Adrian Banning

November 05, 2021

CTO PCI Ups Survival Amid High Ischemia Burden in Single-Center Registry

News Daily News

CTO PCI Ups Survival Amid High Levels of Ischemia in Single-Center Series

Yael L. Maxwell

July 05, 2021

Differentiating Type 1 and Type 2 MI Still ‘Both Art and Science’

News Daily News

Differentiating Type 1 and Type 2 MI Still ‘Both Art and Science’

April 23, 2021

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

February 08, 2021

Can microvascular coronary dysfunction co-exist with SCAD?

Presentation SCAD 2021

Can microvascular coronary dysfunction co-exist with SCAD?

Presenter: Tara Sedlak

January 30, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.